Company: ANIX
Filing Date: 2025-09-10
Form Type: S-3
Source: 0001493152-25-013010
Chunk: 5

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: S-3
Chunk 5
---
. See “Risk Factors” beginning on page 5 and the risk factors in our most recent Annual Report on Form 10-K, which is incorporated by reference herein, as well as in any other recently filed quarterly or current reports and, if any, in the relevant prospectus supplement. We urge you to carefully read this prospectus and the accompanying prospectus supplement, together with the documents we incorporate by reference, describing the terms of these securities before investing.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this Prospectus is _____________, 2025.</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                           | Page |
| About This Prospectus                                     |    1 |
| Cautionary Statement Regarding Forward-Looking Statements |    2 |
| Prospectus Summary                                        |    3 |
| Risk Factors                                              |    5 |
| Use of Proceeds                                           |    6 |
| Plan of Distribution                                      |    7 |
| Description of Securities We May Offer                    |    9 |
| Forms of Securities                                       |   19 |
| Legal Matters                                             |   20 |
| Experts                                                   |   20 |
| Where You Can Find Additional Information                 |   20 |
| Incorporation of Documents By Reference                   |   20 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a “shelf” registration process. Under this shelf registration process, we may offer and sell, either individually or in combination, in one or more offerings, any of the securities described in this prospectus, for total gross proceeds of up to $200,000,000. This prospectus provides you with a general description of the securities we may offer. Each time we offer securities under this prospectus, we will provide a prospectus supplement to this prospectus that will contain more specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the